ArticleCurrent oncology (Toronto, Ont.)2025

Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil.

Heloisa Resende et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.